A prospective study of new infections with herpes simplex virus type 1 and type 2. Chiron HSV Vaccine Study Group

Clicks: 368
ID: 113263
1999
Free PDF
Article Quality & Performance Metrics
Overall Quality Improving Quality
0.0 /100
Combines engagement data with AI-assessed academic quality
AI Quality Assessment
Not analyzed
Abstract
Nearly 40 percent of newly acquired HSV-2 infections and nearly two thirds of new HSV-1 infections are symptomatic. Among sexually active adults, new genital HSV-1 infections are as common as new oropharyngeal HSV-1 infections.
Reference Key
ag1999thea Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Langenberg AG;Corey L;Ashley RL;Leong WP;Straus SE;;
Journal The New England journal of medicine
Year 1999
DOI
DOI not found
URL
http://www.ncbi.nlm.nih.gov/pubmed/10547406
Keywords
National Center for Biotechnology Information NCBI NLM MEDLINE humans pubmed abstract nih national institutes of health national library of medicine adult female male adolescent aged middle aged united states / epidemiology Prospective Studies randomized controlled trials as topic Multicenter Study Seroepidemiologic Studies l corey herpes genitalis / transmission herpes simplex / epidemiology* herpes simplex / transmission herpesvirus 1 herpesvirus 2 herpes genitalis / epidemiology* pmid:10547406 doi:10.1056/nejm199911043411904 a g langenberg s e straus herpes genitalis / microbiology herpes simplex / microbiology human* / isolation & purification oropharynx / virology

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.